Author
Listed:
- Christin Henning
(Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria)
- Gaby Sroczynski
(Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria)
- Lára Hallsson
(Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria)
- Beate Jahn
(Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria)
- Uwe Siebert
(Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria
ONCOTYROL - Center for Personalized Cancer Medicine, Division of Health Technology Assessment and Bioinformatics, Innsbruck, Austria
Harvard T.H. Chan School of Public Health, Center for Health Decision Science, Department of Health Policy and Management, Boston, MA, USA
Harvard Medical School, Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Boston, MA, USA)
- Nikolai Mühlberger
(Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL – University for Health Sciences and Technology, Hall i.T., Austria)
Abstract
No abstract is available for this item.
Suggested Citation
Christin Henning & Gaby Sroczynski & Lára Hallsson & Beate Jahn & Uwe Siebert & Nikolai Mühlberger, 2026.
"Reconsidering Cancer Screening, Cancer-Specific Mortality, and Overdiagnosis: A Public Health and Ethical Perspective—Reply,"
Medical Decision Making, , vol. 46(2), pages 128-129, February.
Handle:
RePEc:sae:medema:v:46:y:2026:i:2:p:128-129
DOI: 10.1177/0272989X251401830
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:46:y:2026:i:2:p:128-129. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.